Patient-derived tau seeding models could be a useful tool to uncover seed-competent tau species, which will hopefully enable tau-targeted tauopathy treatments to be specifically tailored to the deleterious form of tau proteins in tauopathies. Here, MAPT is linked to tauopathy.